Bladder Cancer: Study of Pembrolizumab With or Without Platinum-based Combination
Chemotherapy Versus Chemotherapy Alone in Urothelial Carcinoma
Which of 3 treatments will work better at treating your type of cancer?
Basic Study Information
Purpose:Location: cancer center
If you agree to and are allowed to participate in this study, you will be assigned
by 33% chance (a process called randomization similar to rolling a dice) to one of
three treatment groups:
• Subjects assigned to Treatment Group A, will receive pembrolizumab
• Subjects assigned to Treatment Group B, will receive the combination of pembrolizumab
and chemotherapy (either cisplatin or carboplatin with gemcitabine).
• Subjects assigned to Treatment Group C, will receive chemotherapy (either cisplatin
or carboplatin with gemcitabine).
Both you and your doctor will know which treatment group you have been assigned to.
Study Web URL: https://clinicaltrials.gov/ct2/show/NCT02853305?term=3475-361&rank=1
Study Reference #: IGUB-16125
Lead Researcher (Principal Investigator)
Lead Researcher: Elizabeth Guancial
Study Contact InformationStudy Coordinator: Park Bogan
Phone: (585) 275-3351
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search